Hillevax Insiders
| HLVXDelisted Stock | USD 2.09 0.00 0.00% |
Hillevax employs about 14 people. The company is managed by 9 executives with a total tenure of roughly 33 years, averaging almost 3.0 years of service per executive, having 1.56 employees per reported executive. Break down of Hillevax's management performance can provide insight into the company performance.
Hillevax |
Hillevax Management Team Effectiveness
The company has return on total asset (ROA) of (0.1448) % which means that it has lost $0.1448 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.4031) %, meaning that it created substantial loss on money invested by shareholders. Hillevax's management efficiency ratios could be used to measure how well Hillevax manages its routine affairs as well as how well it operates its assets and liabilities.Hillevax has a total of 50.13 Million outstanding shares. The majority of Hillevax outstanding shares are owned by outside corporations. These institutional investors are usually referred to as non-private investors looking to purchase positions in Hillevax to benefit from reduced commissions. Consequently, third-party entities are subject to a different set of regulations than regular investors in Hillevax. Please pay attention to any change in the institutional holdings of Hillevax as this could imply that something significant has changed or is about to change at the company. Please note that no matter how many assets the company holds, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Some institutional investors establish a significant position in stocks such as Hillevax in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of Hillevax, and when they decide to sell, the stock will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.
Hillevax Workforce Comparison
Hillevax is rated below average in number of employees category among its peers. The total workforce of Health Care industry is currently estimated at about 967. Hillevax claims roughly 14.0 in number of employees contributing just under 2% to equities under Health Care industry.
Hillevax Insider Trading
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Hillevax insiders, such as employees or executives, is commonly permitted as long as it does not rely on Hillevax's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Hillevax insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Aditya Kohli over three months ago Disposition of 6000 shares by Aditya Kohli of Hillevax at 15.4482 subject to Rule 16b-3 | ||
Hilleman Jeryl L over six months ago Acquisition by Hilleman Jeryl L of 17199 shares of Hillevax subject to Rule 16b-3 | ||
Cocero Nanette over six months ago Acquisition by Cocero Nanette of 22500 shares of Hillevax at 13.75 subject to Rule 16b-3 | ||
David Socks over six months ago Discretionary transaction by David Socks of tradable shares of Hillevax subject to Rule 16b-3 | ||
Sepulveda Jaime over six months ago Disposition of tradable shares by Sepulveda Jaime of Hillevax subject to Rule 16b-3 | ||
Borkowski Astrid over six months ago Disposition of 5000 shares by Borkowski Astrid of Hillevax at 13.0 subject to Rule 16b-3 | ||
Shane Maltbie over a year ago Disposition of 4345 shares by Shane Maltbie of Hillevax at 1.7627 subject to Rule 16b-3 | ||
Shane Maltbie over a year ago Disposition of 46 shares by Shane Maltbie of Hillevax at 1.89 subject to Rule 16b-3 |
Hillevax Notable Stakeholders
A Hillevax stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Hillevax often face trade-offs trying to please all of them. Hillevax's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Hillevax's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Shane Maltbie | CFO Treasurer | Profile | |
| Aditya Kohli | CoFounder Director | Profile | |
| Anju Chatterji | VP Operations | Profile | |
| Kaia Agarwal | VP Affairs | Profile | |
| Astrid MD | Chief Officer | Profile | |
| Sean McLoughlin | Chief Officer | Profile | |
| Paul JD | Secretary Counsel | Profile | |
| Ozzie Berger | Senior Affairs | Profile | |
| David Socks | Chief Officer | Profile |
About Hillevax Management Performance
The success or failure of an entity such as Hillevax often depends on how effective the management is. Hillevax management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Hillevax management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Hillevax management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
HilleVax, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel vaccines. It is developing HIL-214, a virus-like particle-based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis caused by norovirus infection. Hillevax operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 15 people.
Please note, the imprecision that can be found in Hillevax's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Hillevax. Check Hillevax's Beneish M Score to see the likelihood of Hillevax's management manipulating its earnings.
Hillevax Workforce Analysis
Traditionally, organizations such as Hillevax use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Hillevax within its industry.Hillevax Manpower Efficiency
Return on Hillevax Manpower
| Revenue Per Employee | 0.0 | |
| Revenue Per Executive | 0.0 | |
| Net Loss Per Employee | 10.5M | |
| Net Loss Per Executive | 16.4M | |
| Working Capital Per Employee | 11.6M | |
| Working Capital Per Executive | 18M |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing. You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.
Other Consideration for investing in Hillevax Stock
If you are still planning to invest in Hillevax check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Hillevax's history and understand the potential risks before investing.
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data |